Catalyst Wire Dossier Catalyst Wire Dossier

Fluticasone Furoate/ Umeclidinium/ Vilanterol

· GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Fluticasone Furoate/ Umeclidinium/ Vilanterol, covering 2019-03-25 to 2020-04-24. Get the full timeline:

Most recent: Clinical Trial Update: A Comparative Study Between Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Single Inhaler Triple Therapy Versus Tiotropium Monotherapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD) [Phase 4]

See pricing